The Importance of the Knee Joint Meniscal Fibrocartilages as Stabilizing Weight Bearing Structures Providing Global Protection to Human Knee-Joint Tissues

• Published in: Cells (Basel, Switzerland) Vol. 8; no. 4; p. 324
• Main Author: Melrose, James
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 06.04.2019; MDPI
• Subjects: Arthritis; Biomarkers; Biomechanics; Cartilage; Cartilage (articular); Cartilage diseases; Chemokines; Collagen; Cytokines; Degeneration; Drug delivery; Fibrocartilage - physiology; Gene expression; Glycoproteins; Growth factors; Histology; Homeostasis; Humans; Hydrogels; Inflammation; Interleukin 1; Joint and ligament injuries; Knee; Knee Joint - physiology; knee stabilization; Laboratories; Magnetic resonance imaging; meniscal biomarkers; Meniscus; Meniscus - physiology; mesenchymal stem cell; Metalloproteinase; Osteoarthritis; Pathology; Progenitor cells; Proteoglycans; Review; rheumatoid arthritis; Stem cells; Subchondral bone; Synovium; Tendons; Thrombospondin; Transcriptome - genetics; Tumor necrosis factor; Tumors; Weight-Bearing; Wound Healing; mesenchymal stem cell; meniscal biomarkers; meniscus; osteoarthritis; weight bearing; knee stabilization; rheumatoid arthritis
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells8040324

The aim of this study was to review aspects of the pathobiology of the meniscus in health and disease and show how degeneration of the meniscus can contribute to deleterious changes in other knee joint components. The menisci, distinctive semilunar weight bearing fibrocartilages, provide knee joint stability, co-ordinating functional contributions from articular cartilage, ligaments/tendons, synovium, subchondral bone and infra-patellar fat pad during knee joint articulation. The meniscus contains metabolically active cell populations responsive to growth factors, chemokines and inflammatory cytokines such as interleukin-1 and tumour necrosis factor-alpha, resulting in the synthesis of matrix metalloproteases and A Disintegrin and Metalloprotease with ThromboSpondin type 1 repeats (ADAMTS)-4 and 5 which can degrade structural glycoproteins and proteoglycans leading to function-limiting changes in meniscal and other knee joint tissues. Such degradative changes are hall-marks of osteoarthritis (OA). No drugs are currently approved that change the natural course of OA and translate to long-term, clinically relevant benefits. For any pharmaceutical therapeutic intervention in OA to be effective, disease modifying drugs will have to be developed which actively modulate the many different cell types present in the knee to provide a global therapeutic. Many individual and combinatorial approaches are being developed to treat or replace degenerate menisci using 3D printing, bioscaffolds and hydrogel delivery systems for therapeutic drugs, growth factors and replacement progenitor cell populations recognising the central role the menisci play in knee joint health.